down arrow

Zim Laboratories

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
87.89
1.24 (1.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 33.42 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Cipla
Sun Pharma.Inds.
Torrent Pharma
Venus Remedies
Lyka Labs
Zenotech Lab.
Kerala Ayurveda
Mankind Pharma
Valiant Laborato
Zim Laboratories
Why is Zim Laboratories Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 9.55%
  • Poor long term growth as Net Sales has grown by an annual rate of 5.07% and Operating profit at 16.41% over the last 5 years
2
The company has declared Negative results for the last 3 consecutive quarters
  • INTEREST(9M) At Rs 8.48 cr has Grown at 63.08 %
  • PBT LESS OI(Q) At Rs 3.95 cr has Fallen at -33.05 %
  • PAT(Q) At Rs 4.00 cr has Fallen at -16.3 %
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 10-Feb-25 and has generated -16.15% returns since then
  • The stocks MACD and KST technical factors are also Bearish
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -10.46% returns in the last 1 year, the stock has also underperformed BSE 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Zim Laboratories for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Zim Laboratories
-9.71%
-0.23
44.91%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
5.07%
EBIT Growth (5y)
16.41%
EBIT to Interest (avg)
3.30
Debt to EBITDA (avg)
2.00
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.29
Tax Ratio
26.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.45%
ROCE (avg)
9.39%
ROE (avg)
7.73%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
27
Industry P/E
33
Price to Book Value
1.74
EV to EBIT
19.86
EV to EBITDA
11.55
EV to Capital Employed
1.53
EV to Sales
1.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.98%
ROE (Latest)
6.65%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-12What is not working for the Company
INTEREST(9M)

At Rs 8.48 cr has Grown at 63.08 %

PBT LESS OI(Q)

At Rs 3.95 cr has Fallen at -33.05 %

PAT(Q)

At Rs 4.00 cr has Fallen at -16.3 %

Loading Valuation Snapshot...
Here's what is not working for Zim Laboratories
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 3.95 cr has Fallen at -33.05 %
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Interest - Nine Monthly
At Rs 8.48 cr has Grown at 63.08 %
over preceding nine months period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Profit After Tax (PAT) - Quarterly
At Rs 4.00 cr has Fallen at -16.3 %
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Non Operating Income - Quarterly
Highest at Rs 1.75 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income